1. Home
  2. BOX vs ICUI Comparison

BOX vs ICUI Comparison

Compare BOX & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

SELL

Current Price

$43.04

Market Cap

4.9B

Sector

Technology

ML Signal

SELL

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$166.98

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
ICUI
Founded
2005
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.0B
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
BOX
ICUI
Price
$43.04
$166.98
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
$39.86
★ $193.38
AVG Volume (30 Days)
★ 2.4M
193.4K
Earning Date
12-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 100.62
EPS
0.18
★ 1.96
Revenue
$506,142,000.00
★ $2,231,262,000.00
Revenue This Year
$9.58
N/A
Revenue Next Year
$8.87
$4.44
P/E Ratio
$239.06
★ $85.24
Revenue Growth
★ 26.98
N/A
52 Week Low
$21.34
$113.37
52 Week High
$43.22
$192.85

Technical Indicators

Market Signals
Indicator
BOX
ICUI
Relative Strength Index (RSI) 83.13 55.69
Support Level $23.52 $164.09
Resistance Level N/A $167.67
Average True Range (ATR) 1.04 4.51
MACD 0.56 0.85
Stochastic Oscillator 90.88 86.13

Price Performance

Historical Comparison
BOX
ICUI

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: